Lifeboat Foundation

Different types of cancer have unique molecular “fingerprints” which are detectable in early stages of the disease and can be picked up with near-perfect accuracy by small, portable scanners in just a few hours, according to a study published today in the journal Molecular Cell.

The discovery by researchers at the Centre for Genomic Regulation (CRG) in Barcelona sets the foundation for creating new, non-invasive diagnostic tests that detect different types of cancer faster and earlier than currently possible.

The study centers around the ribosome, the protein factories of a cell. For decades, ribosomes were thought to have the same blueprint across the human body. However, researchers discovered a hidden layer of complexity—tiny chemical modifications which vary between different tissues, developmental stages, and disease.

A research team from the Nagoya University Graduate School of Medicine has discovered a promising way to slow the progression of heart failure in mice. They fed mice a diet rich in the soybean protein, β-conglycinin (β-CG), which can support heart health by influencing gut bacteria. Their analysis revealed that the soybean protein rich diet increased the production of the short-chain fatty acids (SCFAs) in the intestine that play a role in protecting the heart. Their findings were published in Clinical Nutrition.

Many people with heart problems try to eat a nutritious diet to reduce their risk of disease. As part of a healthy diet, soybeans have long been recognized for their antioxidant and anti-inflammatory properties. Based on this, the researchers suspected that proteins in soy may help prevent heart damage.

Dr. Nozomi Furukawa and colleagues fed the soy-derived protein β-CG to mice prone to heart failure and investigated its effects on the heart. The mice showed improved heart function, less muscle thickening, and reduced scarring of the heart tissue, common problems associated with the progression of heart disease.

Nonlinear optics explores how powerful light (e.g. lasers) interacts with materials, resulting in the output light changing colour (i.e. frequency) or behaving differently based on the intensity of the incoming light. This field is crucial for developing advanced technologies such as high-speed communication systems and laser-based applications. Nonlinear optical phenomena enable the manipulation of light in novel ways, leading to breakthroughs in fields like telecommunications, medical imaging, and quantum computing. Two-dimensional (2D) materials, such as graphene—a single layer of carbon atoms in a hexagonal lattice—exhibit unique properties due to their thinness and high surface area. Graphene’s exceptional electronic properties, related to relativistic-like Dirac electrons and strong light-matter interactions, make it promising for nonlinear optical applications, including ultrafast photonics, optical modulators, saturable absorbers in ultrafast lasers, and quantum optics.

Dr. Habib Rostami, from the Department of Physics at the University of Bath, has co-authored pioneering research published in Advanced Science. This study involved an international collaboration between an experimental team at Friedrich Schiller University Jena in Germany and theoretical teams at the University of Pisa in Italy and the University of Bath in the UK. The research aimed to investigate the ultrafast opto-electronic and thermal tuning of nonlinear optics in graphene.

This study discovers a new way to control high-harmonic generation in a graphene-based field-effect transistor. The team investigated the impact of lattice temperature, electron doping, and all-optical ultrafast tuning of third-harmonic generation in a hexagonal boron nitride-encapsulated graphene opto-electronic device. They demonstrated up to 85% modulation depth along with gate-tuneable ultrafast dynamics, a significant improvement over previous static tuning. Furthermore, by changing the lattice temperature of graphene, the team could enhance the modulation of its optical response, achieving a modulation factor of up to 300%. The experimental fabrication and measurement took place at Friedrich Schiller University Jena. Dr. Rostami played a crucial role in the study by crafting theoretical models. These models were developed in collaboration with another theory team at the University of Pisa to elucidate new effects observed in graphene.

Globally, approximately 139 million people are expected to have Alzheimer’s disease (AD) by 2050. Magnetic resonance imaging (MRI) is an important tool for identifying changes in brain structure that precede cognitive decline and progression with disease; however, its cost limits widespread use.

A new study by investigators from Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham health care system, demonstrates that a simplified, low magnetic field (LF) MRI machine, augmented with machine learning tools, matches conventional MRI in measuring brain characteristics relevant to AD. Findings, published in Nature Communications, highlight the potential of the LF-MRI to help evaluate those with cognitive symptoms.

“To tackle the growing, global health challenge of dementia and cognitive impairment in the aging population, we’re going to need simple, bedside tools that can help determine patients’ underlying causes of cognitive impairment and inform treatment,” said senior author W. Taylor Kimberly, MD, Ph.D., chief of the Division of Neurocritical Care in the Department of Neurology at MGH.

Failing hearts nearly returned to full function in laboratory pigs after they received an experimental gene therapy.

New research shows the gene therapy didn’t just prevent heart failure from worsening in four lab pigs, but actually prompted hearts to repair and grow stronger.

“Even though the animals are still facing stress on the heart to induce heart failure, we saw recovery of heart function and that the heart also stabilizes or shrinks,” said co-senior researcher Dr. TingTing Hong, an associate professor of pharmacology and toxicology at the University of Utah.

Achieving the aggregation of different mutation types at multiple genomic loci and generating transgene-free plants in the T₀ generation is an important goal in crop breeding. Although prime editing (PE), as the latest precise gene editing technology, can achieve any type of base substitution and small insertions or deletions, there are significant differences in efficiency between different editing sites, making it a major challenge to aggregate multiple mutation types within the same plant.

Recently, a collaborative research team led by Li Jiayang from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy of Science, developed a multiplex gene editing tool named the Cas9-PE system, capable of simultaneously achieving precise editing and site-specific random mutagenesis in rice.

By co-editing the ALS^S627I gene to confer resistance to the herbicide bispyribac-sodium (BS) as a selection marker, and using Agrobacterium-mediated transient transformation, the researchers also achieved transgene-free gene editing in the T₀ generation.

The shift from an awake state to unconsciousness is a phenomenon that has long captured the interest of scientists and philosophers alike, but how it happens has remained a mystery—until now. Through studies on rats, a team of researchers at Penn State has pinpointed the exact moment of loss of consciousness due to anesthesia, mapping what happens in different brain regions during that moment.

The study has implications for humans as well as for other types of loss of consciousness, such as sleep, the researchers said. They published their results in Advanced Science.

“People in the neuroscience field generally understand what happens to a patient who is going under anesthesia at a molecular level,” said corresponding author Nanyin Zhang, the Dorothy Foehr Huck and J. Lloyd Huck Chair in Brain Imaging and professor of biomedical engineering at Penn State.

Summary: The dural sinuses and skull bone marrow serve as key communication hubs between the brain’s central immune system and the body’s peripheral immune system. These regions may act as “traffic lights,” allowing immune signals to flow between the brain and body, challenging the traditional view of the blood-brain barrier as an absolute divide.

Researchers found inflammatory activity in these areas correlates with inflammation in both the brain and body, offering new insights into conditions like depression. This discovery could pave the way for innovative treatments targeting these hubs to address immune-related conditions more precisely.

Therapeutic mRNAs offer great potential as a versatile and precise tool against cancer and other diseases. However, the therapeutic effectiveness is limited by the poor translation uptake of naked mRNA. To circumvent this challenge, researchers from VIB, VUB, Ghent University, and eTheRNA Immunotherapies developed an immunotherapeutic platform based on lipid-based nanoparticles (LNPs).

In different cancer models, applying a novel mixture of immunotherapeutic mRNA encapsulated in LNPs led to a clearly improved therapeutic efficacy with limited side effects. This proves the added value of the platform to the development of effective mRNA immunotherapies. The work is published in the journal Nature Communications.

The COVID-19 pandemic and recent Nobel Prize recognition have spotlighted mRNA therapies as a promising approach for diseases like cancer. With precision, scalability, and controlled immune activation, mRNA-based immunotherapy can encode proteins that stimulate the immune system to target and destroy cancer cells. Yet, naked mRNA is unstable, prone to degradation, and poorly absorbed by cells, limiting its effectiveness. This makes the development of reliable delivery methods essential for the future success of mRNA immunotherapies.